26/06/2023
חברת פיביוסק מדיקל, החברה בחטיבה הטכנולוגית של לשכת המסחר, והנה חברת סטארט-אפ, המפתחת שתלים להחלפה מלאה של פרק שורש כף היד, ציינה לאחרונה אבן דרך חשובה בהתקדמות פעילותה:
Last week marked a significant milestone for us! Respected hand surgeons from one of Israel's premier hospitals conducted trials with our fully-developed WristArt device on fresh/frozen cadavers.
This was the first of such tests by external experts. The hand surgeons were very satisfied with the results of the cadaver implantation surgery, and we’d like to express our gratitude for their participation.
These trials with fresh/frozen cadavers are essential in understanding how orthopedic devices like WristArt will function in living patients. These tests came after our successful trials on preserved cadavers, which facilitated the final stages of WristArt's development.
With our sights set on the next major milestone, our first in human trial scheduled for later this year, we extend our thanks for the continued support. Join us on this exciting journey, and stay tuned
for more updates.
גרסה להדפסה
